2026 International Congress Archives - Page 19 of 208

Data Driven Clinical Insights from Longitudinal Cloud-Aggregated Neural Data to Inform a Real-World Adaptive DBS Programming

O. Vaou, K. Matulis, P. Coss, S. Horn, L. Saadatpour, H. Zander, A. Becker, R. Raike, R. Molina (San Antonio, USA)
Data-driven Longitudinal Trajectories of Hippocampal Volume in Parkinson’s Disease and Across the Neurodegenerative Disease Spectrum

U. Saeed, S. E Black, C. Marras, M. A Binns, D. P Breen, K. N Fishman, D. A Grimes, B. Levine, P. M Mclaughlin, A. K Troyer, R. Bartha, H. Zetterberg, A. E Lang, M. Masellis (Toronto, Canada)
Data-driven operational definition of square-wave jerks to optimize diagnostic discrimination of progressive supranuclear palsy

D. Nguyen (Brisbane, Australia)
Data-driven Trajectories of Atrophy Explain Clinical Heterogeneity Across Lewy Body Diseases

A. Konuri, G. Leal, T. Transcend Consortium, G. Halliday, S. Lewis, R. Weil, R. Landin-Romero, C. Lambert, N. Oxtoby, E. Matar (Sydney, Australia)
DBS Evoked Cortical Potentials Can Predict Tremor Suppression

TA. Dembek, C. Schedlich-Teufer, E. Reise, C. Van-Der-Linden, JN. Petry-Schmelzer, V. Visser-Vandewalle, A. Horn, MT. Barbe (Cologne, Germany)
DBS withdrawal syndrome in Parkinson’s disease: Clinical features and outcomes of two new cases

E. Ottela, J. Rönkä, V. Kaasinen, J. Joutsa (Turku, Finland)
DCN-PPN Pathway Activation Improves Motor Dysfunction via Synaptic Plasticity in Parkinson’s Disease

L. Liao, Z. Zhang (Guangzhou, Guangdong Province, China)
DCTN1 Gene: A p.(Gly59Ser) Family Report

G. Fabris, C. Fogliano, G. Bonato, G. Sorarù, A. Antonini, M. Carecchio, M. Campagnolo (Padova, Italy)
DDX17 Drives Astrocytic Mitochondrial Metabolic Reprogramming and Contributes to Parkinson’s Disease Progression

XIA. Dong, GAN. Wu, XIN. Yang, QIN. Li, FUR. Jin, RUI. Li, HON. Li, RUI. Xu (kunming, China)
Decentralized Clinical Trial of a Phase 3 Light Therapy Device for Parkinson’s Disease: Feasibility, Safety, and Efficacy

S. Hussain, C. Alessi-Fox, M. Kostrzebski, K. Murphy, M. Porto, K. Schmier, K. Clark, A. Mcgarry, J. Adams, K. Hendrix, S. Hendrix, D. Adams, E. Dorsey, AND. The Light-Pd Investigators (San Francisco, USA)
Deciphering the NLRP3-Driven Olfactory–Brain Axis in Parkinson’s disease: Neuroprotective Role of Betulin

A. Kumar, V. Malhotra (Ahamdabad, India)
Decoding Deep Brain Activity from Cortical Signals using Deep Learning across Movement Disorders

ZX. Yin, WJ. Neumann, JG. Zhang (Berlin, Germany)
Decoding Parkinson’s Disease Metabolic Landscape: Targeted 4D-Metabolomics of Urinary Amine-Phenol Submetabolomes for Specific Signature Identification and Biomarker Discovery

Y. Zhang, X. Huang, Y. Zhou, C. Shen, L. Cao (Shanghai, China)
Deep Brain Stimulation (DBS) For Parkinson’s Disease (PD) Patients Carrying The GBA Gene Variant: Greater-Than-Expected Benefits, Similar Cognitive Decline, But Caution Is Advised Regarding Anxiety And Depression.

OBP. Bernal-Pacheco, DSP. Poveda-Rodriguez, NTL. Lopez-Gonzalez (Bogota, Colombia)
Deep brain stimulation effects on Parkinson’s disease patients with orthostatic hypotension

D. Samayoa, H. Takeshige-Amano, S. Ueno, E. Igami, A. Kakimoto, S. Ueno, M. Shimizu, H. Iwamuro, A. Umemura, T. Hatano (Bunkyo-ku, Japan)
Deep Brain Stimulation for Focal Abdominal Dystonia

C. França, P. Kimaid, A. Moreira, F. Godinho (São Paulo, Brazil)
Deep brain stimulation improves levodopa-induced dyskinesias beyond medication reduction in Parkinson’s disease

C. Reyes, C. Martínez, J. Fonseca, F. Castro, A. Calderón, L. Reyes, C. Ramírez (Ciudad de México, Mexico)
Deep Brain Stimulation Outcomes in Parkinson’s Disease Patients With GBA1 Variants: A Systematic Review and Meta-analysis

A. Hegazi, R. Mohamed, H. Hussein (Mansoura, Egypt)
Deep learning-derived progression network in isolated REM sleep behavior disorder

N. Nguyen, A. Vo, S. Peng, D. Truong, P. Wu, C. Zuo, J. Lee, Y. Ma, D. Eidelberg (Shanghai, China)
Deep Learning-Enhanced Multimodal MRI for Real-World Differentiation of Parkinsonian Disorders

S. Hartono, H. Ulfah, Q. Sun, C. Liu, D. Patidar, P. Seow, P. Chai, Q. Lyu, R. Chen, E. Tan, L. Chan (Singapore, Singapore)
Default Mode Network Co-Activation Pattern Dynamics and Their Relationship to Cognition in Parkinson’s Disease with and without Mild Cognitive Impairment

P. Chunchu, N. Singhal, T. Davis, V. Mari, V. Mishra (Birmingham, USA)
Defining a Population-Based Cohort of Individuals with Probable REM Sleep Behavior Disorder

K. Eid, M. Flores-Torres, A. Hung, M. Schwarzschild, A. Ascherio, K. Bjornevik (Boston, USA)
Degradation Mechanisms of PolyG

YL. Chen, W. Luo (Hangzhou, China)
Delayed Parkinsonism Following Japanese Encephalitis: A Case Report with Dopamine Transporter Imaging and L-dopa/DCI treatment

R. Yui, Y. Kobayashi, G. Okumura, M. Katagiri, C. Yuzawa, Y. Shimizu (Ina, Japan)
Delayed Parkinsonism in Anti‑NMDAR Encephalitis Following Immunotherapy – A Rare Clinical Manifestation

C. Irawan, D. Tunjungsari, A. Tiksnadi (Jakarta, Indonesia)
Delayed-Onset Rapidly Progressive Parkinsonism After BCMA×CD3 Bispecific Antibody Therapy: A Case Report

IF. Yang, TY. Chung, YF. Sung (Taipei, Taiwan)
Delineating Therapeutic and Non-therapeutic Neural Signatures of Deep Brain Stimulation

T. Sil, P. Navratil, G. Abbas, J. Volkmann, M. Muthuraman, M. Reich, R. Peach (Wuerzburg, Germany)
Demographic And Clinical Characteristics Of Advanced Parkinson’s Disease Patients Receiving Levodopa–Entacapone–Carbidopa Intestinal Gel (LECIG) In The ELEGANCE Study: An Updated Interim Analysis

S. Singh, N. Smith, B. Amlani (Reading, United Kingdom)
Demystifying the Delivery of Multi-arm Multi-stage Platform Trials for Parkinson’s Disease –Framework and Recommendations from EJS ACT-PD

C. Girges, J. Inches, L. Brennan, G. Mills, M. Zeissler, E. de Pablo-Fernandez, C. Pugh, C. Gonzalez-Robles, R. Gurney, S. Collins, C. Murphy, C. Carroll, T. Foltynie (Plymouth, United Kingdom)
Dentate Glutamate as an OFF-State Biomarker of Levodopa-Resistant Postural Tremor in Parkinson’s Disease

S. Prasad, A. Xavier, D. Deelchand, M. Kumar, R. Yadav, P. Pal, J. Saini (Bengaluru, India)
Dentatothalamic Projections Mediate Tremor Relief Across Deep Brain Stimulation Targets and Tremor Types

C. Van-Der-Linden, T. Dembek, V. Visser-Vandewalle, A. Horn, M. Barbe, J. Petry-Schmelzer (Cologne, Germany)
Depression and Psychosis in military Veterans with Parkinson’s Disease (PD)

A. Sarwar, P. Bigner (Houston, USA)
Depressive Symptoms and Functional Impairment in Huntington’s Disease A Brazilian Cohort Study

D. Corrêa, D. Maia, R. Maciel, F. Cardoso (Belo Horizonte, Brazil)
Describing Factors Associated with Progression in Parkinson’s Disease: A Retrospective Chart Review

S. Rodrigo, T. Anderson, C. Goetz (Chicago, USA)
Designing a virtual reality-based rehabilitation therapy for Parkinson disease

BA. Lopez, RD. Jamora, VM. Anlacan, IT. Salido, BA. Galecio, ME. Aguila, CA. Cruz, D. Cruz, A. Rabano, C. Tee, J. Caro, M. Tee (Manila, Philippines)
Detecting Early and Prodromal Parkinson’s Disease in the Elderly Using Multimodality Digital Biomarkers: A Pilot Study

SP. Fan, WS. Lim, KP. Lin, YL. Chiu, CH. Lin (Taipei City, Taiwan)
Detecting Parkinson’s Disease with Postural Sway via Single IMU and Machine Learning

F. Rashid, R. Fernandez-Rojas, S. Dal, M. Ghahramani (Canberra, Australia)
Detecting Repeat Expansions: Added Diagnostic Yield in Movement Disorders by Optical Genome Mapping

M. Pauly, H. Tiefenbach, K. Neveling, M. Thomsen, F. Hinrichs, S. Löns, J. Trinh, A. Dalski, C. Klein, A. Münchau, K. Ullrich, N. Brüggemann, K. Lohmann (Lübeck, Germany)
Detection of heterozygous ATP7B variants in Hawaii’s Parkinson’s Disease cohort: A case series of six patients

M. Faouzi, K. Thai, R. Shuman, E. Krening, F. Gao, PF. Pdgeneration Study, M. Bruno (New York, USA)
Detection of α-synuclein seeds in skin samples from PPMI participants

Y. Ma, C. Farris, R. Johnson, S. Rosete-Gonzalez, D. Murphy, T. Foroud, L. Concha (San Diego, USA)
Determinant factor of tremor recurrence after Vim-FUS in ET and tremor-dominant PD

E. Natera-Villalba, MA. Gorospe, GM. Díaz-Taveras, A. Jiménez-Huete, E. Salinas, A. Martín-Bastida, PM. Cortadi La-Villa, I. Avilés-Olmos, CA. Sánchez-Catasús, A. Arcadi, LH. González-Quarante, J. Guridi, MC. Rodríguez-Oroz (Pamplona, Spain)
Determinants of depression severity in patients of Spinocerebellar ataxia 12

J. Bilga, N. Sawal, A. Prasad (Chandigarh, India)
Determinants of Quality of Life According to Brain-first and Body-first in Patients with Parkinson’s Disease

XN. Liu, YL. Tang, XN. Liang, J. Wang (Shanghai, China)
Determinants of Re-diagnosis of Parkinson’s Disease to Atypical Parkinsonism: Results from the Tracking Parkinson’s Cohort (PRoBAND) and Oxford Parkinson’s Discovery Cohort (OPDC) Cohorts

R. Fumi, D. Vaughan, T. Rittman, J. Rowe, E. Jabbari, A. Nodehi, M. Lawton, T. Zerenner, Y. Ben-Shlomo, D. Grosset, M. Hu, H. Morris (London, United Kingdom)
Determinants of Tremor Control Across Severity Levels Following GPi-Deep Brain Stimulation in Parkinson’s Disease

M. Girija, T. Bhaskar, A. Prabhu, S. Joshua, A. Nair, A. Hynse, A. Kishore (Kochi, India)
Developing a toolkit for the assessment and management of lower urinary tract symptoms in parkinsonism

M. Smith, M. Drake, A. Batla, S. Creavin, C. Murphy, N. Vasquez, J. Panicker, Y. Ben-Shlomo, E. Henderson (Bristol, United Kingdom)
Developing a Unified Advanced Neuromodulation Clinical Pathway for MR-Guided Focused Ultrasound and Deep Brain Stimulation

A. Zoana, M. Lotia, N. Reddy, A. Ahmed, C. Reddy (Celebration, USA)
Developing non-invasive EEG biomarkers for Parkinson’s disease using concurrent subthalamic nucleus/cortical recording as ground truth.

MI. de Bartolo, G. Leodori, M. Mancuso, F. Marchet, F. Aiello, A. Conte, A. Berardelli, D. Belvisi, M. Marano, G. Fabbrini (Rome, Italy)
Development and initial feasibility of a Randomised Pilot Trial of Enhanced Tai Chi for Parkinson’s Disease

M. Qamar, O. Awogbemila, R. Savla, L. Batzu, S. Rota, A. Hernandez Pena, C. Yang, M. Freris, B. Dikong, J. Whitney (London, United Kingdom)
Development and preliminary results of a new self-assessment tool for neuropsychiatric syndromes in Parkinson’s Disease

U. Lambotte, C. Schedlich-Teufer, S. Simon, A. Sauerbier, JC. Baldermann-Weiß, L. Hesse, D. Gruber, G. Ebersbach, W. Jost, E. Kalbe, GR. Fink, J. Kessler, MT. Barbe, SJ. Jost (Wolfach, Germany)
Development of a Clinical Decision Support System to Support Parkinson’s Disease Management.

P. Onyeachu, S. Kim, K. Bounsall, E. Meinert, C. Carroll (Newcastle Upon Tyne, United Kingdom)
Development of a Nationwide Parkinson’s Disease Cohort in Korea: Toward an Ethnicity-Specific Precision Medicine Platform

JS. Kim, DW. Ryu, Y. Oh, S. Ha, SJ. Kim, ES. Oh, YJ. Kim, PH. Lee, SJ. Chung, SB. Koh, DY. Kwon, JW. Cho, JS. Baik, HI. Ma, TB. Ahn, HW. Lee, JK. Park, M. Kwon, YH. Koh, SW. Yoo (Seoul, Republic of Korea)
Development of a Parkinson’s Disease Dyadic Multidisciplinary Illness Management Program: Protocol for PATH Parkinson

K. Kim, J. Lee, S. Chung, J. Kim (Seoul, Republic of Korea)
Development of a Web Based Neuro Recovery Roadmap Prototype for Visualizing and Tracking Multidisciplinary Rehabilitation in Movement Disorders

N. Megayasa (Denpasar, Indonesia)
Development of Motor Complications in Rubral Tremor treated with Levodopa

T. Torabi, J. Ostrem (San Francisco, USA)
Device-aided Therapies are Associated with Significantly Greater Improvement in Quality of Life in Younger Patients Earlier Within Advanced Parkinson’s Disease

D. Santos García, á. Solleiro Vidal, L. López Manzanares, S. Martí Matínez, J. González Ardura, J. Gómez Esteban, T. Delgado, G. González Ortega, E. Cubo, B. Solano, AB. Perona-Moratalla, S. Escalante, á. Monterde Ortega, MP. Gil Martín, R. López Blanco, C. Borrué Fernández, I. Martínez Torres, P. García Ruíz, I. Pareés Moreno, C. Delgado Suárez (A Coruña, Spain)
Device-aided Therapies in Multiple System Atrophy: Long-term Follow-up Case Series

K. Rukavina, H. Stuke, J. Malleike, D. Carneiro, N. Campese, D. Gruber, G. Ebersbach (Beelitz, Germany)
Device-Assisted Therapies in Parkinson Disease: Patient Preference Following Nurse-Led Education

D. Tsui, D. Wilson, S. Bray (Sydney, Australia)
Diagnosing Prodromal Synucleinopathies – What is the Role of Cardiac MIBG Scintigraphy?

G. Chiaro, Z. Jiang, A. Rogeau, J. Bomanji, V. Iodice (London, United Kingdom)
Diagnosis and therapeutic approaches for sialorrhea in patients with Parkinson’s disease.

N. Fedotova, E. Bril, O. Turgunkhujaev, O. Zimnyakova (Moscow, Russian Federation)
Diagnosis and Treatment of Occult Psychogenic Movement Disorder Without Mood Disorder: A Case Report

H. Liang, A. Karimova, C. Liang (Almaty, Kazakhstan)
Diagnostic Accuracy of NPH by Radiographic Suspicion and Effect on Patient Outcomes

S. Yee, J. Miller, L. Acosta (Nashville, USA)
Diagnostic Delay in Multiple System Atrophy: Sociodemographic and Clinical Predictors in a Single-Center Cohort

T. Kaneko, E. Krening, M. Bruno (Honolulu, USA)
Diagnostic Odyssey in L-2-Hydroxyglutaric Aciduria: A Case with Progressive Cerebellar and Extrapyramidal Movement Disorder

A. Saini, S. Mehta (chandigarh, India)
Diagnostic Sensitivity of a Shortened Accelerometry-Based Functional Tremor Battery

M. Cibula, N. Prezelj, R. Berlot, M. Kojović (Ljubljana, Slovenia)
Diagnostic Test Utilization and Timing in a Multidisciplinary Gastrointestinal Symptom Clinic: Insights from the Parkinson’s Research and Integrated Support Model (PRISM) Clinic

G. Hey, M. Beke, N. Walker-Pizarro, C. Rogers, A. Ramirez-Zamora, M. Amaris (Gainesville, USA)
Diagnostic Utility of [18F]FDG-PET in the Differential Diagnosis of Parkinsonian Syndromes: A Retrospective Study in an Indian Tertiary Care Cohort

A. Mani, J. Hephzibah (Ranipet, India)
Diagnostic Utility of Routine 1.5T Brainstem Planimetry in Parkinsonism: Evidence from a Vietnamese Cohort

D. Nguyen, T. Tran (St Lucia, Australia)
Diagnostic Validity of PD Identification in a Neurologist-Certified National Drug Reimbursement Registry

V. Räty, T. Kuusimäki, T. Vahlberg, A-M. Tolppanen, V. Kaasinen (Turku, Finland)
Diet Quality and Nutrient Intake in Parkinson’s Disease: A Multicenter Study in Egypt

E. Abed (Cairo, Egypt)
Dietary and Environmental Risk Factors of Parkinson’s Disease: An Integrated Network Pharmacology Approach

D. Ghosh, P. Basu, S. Mondal, S. Dey, S. Pal (Kolkata, India)
Differences in Levodopa Equivalent Daily Dose (LEDD) Based on Disease Duration in Parkinson’s Disease Patients at RSCM – A Tertiary National Referral Hospital

F. Abdat, A. Tiksnadi, D. Tungjungsari (Jakarta, Indonesia)
Differences in Lewy body dementia in people from ethnic minorities: a systematic review of epidemiology, diagnosis, clinical features and imaging

S. Kalam, A. Zirra, J. Knight, L. Bishop, R. Fernando, C. Marshall, A. Noyce, R. Weil (London, United Kingdom)
Differences in Sleep and Activity Digital Phenotypes from Wrist Accelerometry in Parkinson’s Disease, At‑Risk Individuals, and Healthy Controls

I. Gerasimou, A. Moustaklis, L. Hadjileontiadis, S. Hadjidimitriou (Thessaloniki, Greece)
Differential Cholinergic White Matter Microstructural Alterations in Multiple System Atrophy and Parkinson’s Disease

SM. Rong, R. Yang, ZH. Li, XL. Cui, CT. He, MF. Cai, YH. Zhang (Guangzhou, Guangdong Province, China)
Differential Effect of MAO-B Inhibitors in GBA1 Carriers with Parkinson’s Disease Women vs Men

H. Saragani, R. Henner, M. Cohen, S. Vilk, A. Zimran, I. Harari, R. Eichel, G. Yahalom, M. Cohen (Jerusalem, Israel)
Differential Effects of Digital Self-Monitoring and Multimodal Training in Adults with Sleep Difficulties on Sleep and Psychological Outcomes: Relevance to Parkinson’s Disease

T. Tamir, M. Catalogna, N. Saporta, O. Shoval, S. Molcho, A. Amedi (Herzliya, Israel)
Differential effects of levodopa and subthalamic nucleus deep brain stimulation on the bradykinesia components in Parkinson’s Disease

D. Marín-Medina, M. Wilken, F. Wainberg, M. Merello (Buenos Aires, Argentina)
Differential expression of nucleotide excision repair genes in Parkinson’s disease

PBR. Bermúdez Ramírez, SMS. Salas Pacheco, FCJ. Castellanos Juárez, JSP. Salas Pacheco, ASL. Salas Leal, ASC. Sandoval Carrillo (Durango, Mexico)
Differential Microglial Activation and p-Ser129 Alpha-Synuclein Induction by Neurotropic and Non-Neurotropic Influenza A Virus Strains

L. Ho, D. Nguyen, E. Ko, Y. Kim (Jeju, Republic of Korea)
Differential Oculomotor Patterns in Parkinson’s Disease and Multiple System Atrophy With Predominant Parkinsonism

Y. Liu, P. Tang (Xi'an, China)
Differential Tremor Responses To Transcutaneous Spinal Cord Stimulation Across Tremor Syndromes

R-A. Steopoaie, K. Humaidan, A. Pascual-Valdunciel, J. Ibañez, K. Bhatia, L. Rocchi, A. Latorre (Bucharest, Romania)
Differentiation of Parkinsonian Syndromes Using Cognitive Strategies and Associations with Non-tremor Motor Progression

A. D'Souza, M. Gibbs, H. Emmett, E. Lwin, C. Sotirakis, C. Antoniades (Oxford, United Kingdom)
Diffusion MRI Evidence of Cerebellar Involvement in Cognitive Dysfunction in Parkinson’s Disease

A. Vijayakumari, L. Saadatpour, D. Floden, K. Sakaie, H. Kaur, H. Fernandez, B. Walter (Cleveland, USA)
Diffusion MRI Markers of Neural Reserve: Interaction Between Callosal Integrity and Clinical Vulnerability After Functional Neurosurgery in Parkinson’s Disease

J. Brainer Lima, M. Cavalcanti, P. Brainer Lima, A. Brainer Lima, M. Sales, S. Laurentino, M. Carvalho, P. Brainer Lima (Recife, Brazil)
Digital acoustic assessment of alleviating maneuvers in laryngeal dystonia: a 2-patient case series

I. Khasanov, D. Khasanova (Kazan, Russian Federation)
Digital acoustic biomarkers of botulinum toxin response in laryngeal dystonia: a longitudinal case report

D. Khasanova, I. Khasanov, Z. Zalyalova (Kazan, Russian Federation)
Digital Assessment of Cognitive Function in Parkinson’s Disease: Preliminary Feasibility and Validity Data

M L. Nasi, E. Fiorenzato, L. Weis, F. Vianello, D. Lupi, A. Antonini, R. Biundo (Padova, Italy)
Digital Biomarkers of Spinocerebellar Ataxia Type 3: Wearable Sensor Metrics during Turning and Postural Adjustments

R. Guimarães, J. Diniz, L. Souza, C. Lobo, N. Santos, J. Fernandes, L. Ramalho, A. Martinez, M. França (Campinas, Brazil)
Digital cognitive training and promoting a healthy lifestyle as a booster for cognitive reserve in prodromal Parkinson’s disease?

A. Ophey, S. Röttgen, K. Kufer, J. Pauquet, D. Scharfenberg, P. Armbrust, A. Kammerzell, N. Knopf, S. Kollath, P. Sommer, CEJ. Doppler, E. Farrher, A. Seger, NJ. Shah, D. Zopfs, K. Reetz, GR. Fink, M. Sommerauer, E. Kalbe (Cologne, Germany)
Digital Facial Movement Analysis in Hemifacial Spasm: Potential and Limitations as a Clinical Biomarker

Z. Kosutzka, S. Sepelak, V. Hudzikova (Bratislava, Slovakia)
Digital Gait Biomarkers Reveal a Distinct Motor Prodrome Up to Five Years Before Parkinson’s Disease Diagnosis in the General Population

P. Pelicioni, S. Waller, L. Chan, A. Krishnan, S. Lord, M. Brodie (Randwick, Australia)
Digital Handwriting Analysis: A Useful Tool to Quantify Acute Dopaminergic Response in Parkinson’s Disease

L. Díaz-Feliz, M. Faundez-Zanuy, A. Gennari, P. Sanz-Cartagena, J. Arbelo-Gonzalez, M. García-Cabezas, P. García-Ruiz (Las Palmas GC, Spain)
Digital Health, Telemedicine, and Artificial Intelligence in Parkinson’s Disease Management During COVID-19: A Narrative Review

H. Harifi (Kenitra, Morocco)
Digital Innovation in Parkinson’s Disease – Governing Care and Managing Autonomy

B. Schmitz-Luhn (Bonn, Germany)
Digital Kinematic Measures of Finger Tapping Detect Dose-Dependent Effects of Deep Brain Stimulation in Parkinson’s Disease

G. Acevedo, D. Vuddandam, A. Madamangalam, G. Kenworthy, C. Dehemptinne, J. Cagle, J. Wong (Gainesville, USA)
Digital Mobility Outcomes for Modelling Self-Perceived Gait Security in People with Parkinsonian Disorders

F. Boschi, S. Sapienza, M. Giraitis, G. Zelimkhanov, F. Terranova, H. Gaßner, J. Goncalves, J. Klucken (Belvaux, Luxembourg)
Digital Prediagnostic Mobility and Autonomic Trajectories in a Large Parkinson Disease Network

T. Jansen, A. Hare, R. Gilron (San Francisco, USA)
Digital Respiratory Biomarkers as Early Indicators of Dysphagia and Aspiration Risk in Parkinsons Disease A Systematic Review

M. Kakde, S. Kakde, S. Kakade (Pune, India)
Digital Speech Biomarkers Reveal Speech Changes in Physiological Aging and Parkinson’s Disease

L. Novakova, K. Novotny, D. Kovac, J. Mekyska, I. Rektorova (Brno, Czech Republic)
Digitizing PD Rating Scales Increases Reliability and Accessibility

Z. Yekutieli, Y. Yahalom, P. Lewitt (Tel-Aviv, Israel)
Directional versus Omnidirectional GPi-DBS in Parkinson’s Disease

A. Kishore, M. Girija, S. Joshua, A. Nair, A. Hynse (Kochi, India)
Disabling Holmes Tremor Following Pontine Hemorrhage Accompanied by a Unique Constellation of Movement Disorders

P. Cataniag, J. Cruz, J. Ong, C. Diesta, J. Oropilla, R. Teleg, K. Amamanglon, M. Mendoza (Makati City, Philippines)
Disassembly of α-Synuclein Aggregates by the All-D-peptide PRI-101: Preclinical Efficacy in Vitro and in Vivo.

M. Sevenich, M. Feja, J. Jarazo, S. Reithofer, K. Korostov, S. Schemmert, F. Charbgoo, M. Wendt, G. Tamgüney, J. Schwamborn, F. Richter, D. Willbold, A. Willuweit (40225, Germany)
Discontinuation of Parkinson’s Disease Clinical Studies: A Cross-Sectional Analysis

Y. Alnomani, A. Mady (Benha, Egypt)
Discontinuation Patterns and Predictive Factors in Continuous Subcutaneous Foslevodopa/Foscarbidopa (FLC/FCD) Therapy: Insights from Early Clinical Experience

K. Waqar, M. Thomas, Y. Abdelmajid, E. Freitas, R. Cabrito, RH. Battah, A. Anjum, SH. Mittal (Abu Dhabi, United Arab Emirates)
Discordant Siblings Reveal Determinants of Clinical Penetrance in GBA-Associated Parkinson’s Disease

T. Filidei, SP. Caminiti, R. Malito, P. Mitrotti, R. Calabrese, R. Stiuso, L. Bandirali, L. Gallo, M. Costanzo, P. Di Martino, M. Picascia, A. Pichiecchio, G. Fabbrini, EM. Valente, M. Avenali (Pavia, Italy)
Disease Burden Profile of Patients with Spinocerebellar Ataxia in China: A Real-World Registry Study (2025)

LY. Lu, LF. Zhang, Y. Huang (Beijing, China)
Disease Endophenotyping through Graph and Adjacency Metrics (DEGAS): Network Biomarkers for Parkinson’s Disease Prognosis

A. Martinez-Nunez, M. Okun, J. Wong (Gainesville, USA)
Disease-Modifying Outcomes Following High Intensity Boxing and Sensory Exercise in Parkinson’s Disease: Results From a Double-blinded Randomized Controlled Trial

K. Sangarapillai-Patel, Q. Almeida (Waterloo, Canada)
Disease-specific Polygenic Risk Scores and Development of Incident Parkinson’s Disease in a Large Cohort of Healthy Older Adults.

A. Kuri, S. Waters, J. Bestwick, S. Meyer, R. Benabderrazik, A. Shahid, H. Chohan, E. de Pablo-Fenández, C. Simonet, L. Pérez-Carbonell, A. Lees, G. Giovannoni, A. Schrag, A. Noyce (London, United Kingdom)
Disentangling Disease- and Medication-Associated Gut Microbiome Signatures in Parkinson’s Disease

MG. Choi, SY. Jo, JY. Lee, HN. Im, GY. Lee, SJ. Chung (Seoul, Republic of Korea)
Disparate Subregional Striatal DAT-SPECT Associations with CSF-Synucleinopathy Status and Clinical Severity Across Parkinson’s Disease Continuum

AD. Droby, BK. Krayem, AM. Mirelman, AT. Thaler (Tel Aviv, Israel)
Disparities for Tremor and Dystonia Patients Accessing Deep Brain Stimulation: An Explanatory Sequential Mixed Methods Study

S. Corrick, J. Miyasaki, A. Hyde, S. Poonja, B. Duad Shah, E. Noyes, P. Torabi, K. Yen, G. Dimapilis, T. Sankar, A. Rajput, A. Vitali, B. Oladunni Salami, F. Ba (Edmonton, Canada)
Disparities in Accessing MRI-Guided Focused Ultrasound (MRgFUS) and Gamma Knife for Tremor Treatment: A Retrospective Chart Review

S. Corrick, J. Miyasaki, S. Poonja, P. Torabi, K. Yen, G. Dimapilis, T. Sankar, F. Ba (Edmonton, Canada)
Disrupted Lipid Homeostasis and Mitochondrial Remodeling in A53T α-Synuclein Astrocytes

I. Goglia, SL. Pereira, M. Tziortziou, P. Mulica, S. Delcambre, L. Gallucci, L. Neises, M. Mendes, G. Dittmar, J. Meiser, A. Monzel, E. Glaab, A. Grünewald (Belvaux, Luxembourg)
Disrupted Sleep and Daytime Sleepiness are Associated With Poorer Quality of Life in Advanced Parkinson’s Disease: ROSSINI Interim Results

I. Malaty, T. Henriksen, T. Mestre, R. Rodriguez, P. Schwingenschuh, M. Simu, L. Bergmann, S. Caughlin, M. Gopalkrishnan, P. Kukreja, M. O’Meara, J. Carlos Parra, M. Shah, W. Jost (Gainesville, USA)
Distinct Cognitive Profiles in Parkinson’s and Alzheimer’s Disease: Evidence from a Large Neurodegenerative Cohort

I. Zhukova, M. Matveeva, N. Zhukova, A. Agasheva, D. Novotnyi, S. Shteimetz, Z. Sayfitdinkhuzhaev (Moscow, Russian Federation)
Distinct Cortical and Subcortical Network Mechanisms of High and Low Frequency Subthalamic Stimulation in Parkinsons Disease

Z. Zeng, Z. Lin, C. Zhang, Z. Duan, B. Sun, N. He, P. Peng, D. Li (Shanghai, China)
Distinct FDG PET Metabolic Signatures and Dopaminergic Loss Across Multiple System Atrophy Subtypes

T. Carther-Krone, J. Perron, CS. Lee, JH. Ko (Winnipeg, Canada)
Distinct FDG-PET metabolic patterns and connectivity alterations in dopamine transporter-deficient versus -preserved MSA-C

Y. Zhao, H. Lin, X. Li, J. Ge, F. Liu (Shanghai, China)
Distinct Glymphatic Pathways Underlie Prodromal and Clinical Features of Parkinson’s Disease

J. Choi, M. Kim, A. Kim (Los Angeles, USA)
Distinct HD-EEG Functional Connectivity Patterns in Early-Onset Parkinson’s Disease

C. Simonetta, V. Ferrari, D. Mascioli, F. Carparelli, S. Bagetta, J. Bissacco, M. Pierantozzi, M. Mancini, V. Buttarazzi, K. Meksi, A. Stefani, D. Centonze, T. Schirinzi, M. Conti (Rome, Italy)
Distinct Local and Global Functional Network Reorganization Underlying STN versus GPi DBS in Parkinson’s Disease

H. Ding, K. Xie, B. Bahners, W. He, J. Chen, M. Metzger, B. Nasseroleslami, J. Volkmann, D. Li, M. Muthuraman, C. Zhang (Würzburg, Germany)
Distinct Neurostructural, Cognitive, and Neuropsychiatric Associations of Plasma p-tau217, and Aβ42/40 in Parkinson’s Disease and Aging Cohorts

E. Fiorenzato, S. Cauzzo, G. Musso, R. Biundo, C. Ceolin, C. Fogliano, C. Cosma, W. Meissner, V. Misenti, S. Moz, ML. Nasi, F. Vianello, R. Manara, M. Montagnana, G. Sergi, A. Antonini (Padova, Italy)
Distinct Non-Motor Symptom Progression Subtypes in Parkinson’s Disease Identified Using a Data-Driven SuStaIn Model

JY. Liu, AQ. Huang, SY. Liu, Z. Ruan, P. Chan (Beijing, China)
Distinct Patterns of Perivascular Diffusivity and Choroid Plexus Volume in De Novo Parkinson’s Disease and Type 2 Diabetes

YJ. Bae, C. Shin, H. Jeong, SJ. Cho, SH. Baik, DH. Lee, Y. Jeong, JM. Kim (Gainesville, USA)
Divergent Glymphatic Dysfunction and Free Water Pathology Underpin Distinct Mechanisms and Enable Differential Diagnosis in Parkinson’s Disease and Multiple System Atrophy

RNS. Shen, LCZ. Zhou, JL. Liu (Shanghai, China)
DJ-1 (PARK7) Heterozygous Mutation and Early-Onset Parkinson’s Disease: A Chilean Case Report and Literature Review

K. Guzmán, M. Sanchez, D. Avila (Santiago de Chile, Chile)
Do Digital Mobility Outcomes Differ Across Clinically Defined NSD-ISS Stages in Parkinson’s Disease?

P. Tait, L. Alcock, C. Schlenstedt, C. Caroll, C. Becker, J. Buekers, B. Caulfield, A. Cereatti, S. Del-Din, L. Delgado-Ortiz, J. Garcia-Aymerich, S. Koch, P. Ginis, H. Gassner, A. Nieuwboer, J. Hausdorf, A. Mirelman, L. Rochester, W. Maetzler, A. Yarnall (Newcastle upon Tyne, United Kingdom)
Does Balance Mediate the Relationship Between Aerobic Capacity and Walking Endurance in Parkinson’s Disease?

C. Balasubramaniam, I. Wilkinson, J. Osborne, K. Flanagan, K. Mangipudi (Jacksonville, USA)
Does CANVAS mimic MSA-C

I. Pei, A. Storck, T. Bogdan, C. Tranchant, IJ. Namer, S. Kremer, T. Thomas, M. Anheim (Strasbourg, France)
Does Fall-Related Activity Avoidance Differ between people with Parkinson’s disease versus Cognitively Unimpaired Controls?

M. Lindh-Rengifo, E. Franzén, M. Landers, E. Stomrud, M. Nilsson (Lund, Sweden)
Does Fgatir Hypointensity Predict Outcomes After Deep Brain Stimulation For Action Tremors

N. Kahn, S. Abdelaziz1, F. Baig, I. Cociasu, B. Ishihara, S. Ratti, L. Ricciardi, E. Pereira, F. Morgante, M. Hart (Cairo, Egypt)
Does Knowing More Mean Tolerating More? Satisfaction with Medication Information and Levodopa Dosage in Parkinson’s Disease

M. da Silva, M. Tosin, L. Silveira-Moriyama (Chicago, USA)
Does PET Imaging Modality Influence Artificial Intelligence Performance in Diagnosing Parkinson’s Disease? Diagnostic Test Accuracy Meta-analysis

MH. Elkasaby, MSA. Ahmed (Cairo, Egypt)
Does Subthalamic Nucleus DBS Produce Sustained Improvement in Postural Abnormalities? A 5 Year Prospective Study

M. Siddiqui, R. Shivacharan (Winston Salem, USA)
Does Unilateral MR-Guided Focused Ultrasound Subthalamotomy Provide Bilateral Motor Benefit in Parkinson Disease

E. Navarro-Mocholí, M. Campins-Romeu, R. Conde-Sardón, I. Sastre-Bataller, M. Losada-López, C. Morata-Martínez, MJ. Ibáñez-Julià, MN. Afkir-Ortega, AM. Lozano, A. Gutiérrez-Martín, I. Martínez-Torres (Valencia, Spain)
Dopamine Agonist-Associated Dropped Head Syndrome in Parkinson’s Disease: A Case Series

L. Kovalchick, L. Qian, J. Theo, E. Krause (Austin, USA)
Dopamine and Na,K-ATPase: Mechanisms of Direct Enzyme Modulation in the Hippocampus

G. Chkadua, E. Nozadze, L. Shioshvili, L. Tsakadze, S. Dzneladze, N. Arutinova, M. Leladze, M. Javakhishvili (Tbilisi, Georgia)
Dopamine depletion does not mitigate striatal reward prediction error signals

JH. Shin, JS. Kim, HK. Chung, MW. Jung (Seoul, Republic of Korea)
Dopamine Receptor Blocking Drug Exposure is Associated with Parkinson’s Disease

L. Neilson, R. Carnahan, V. Kijewski, S. Duffy, G. Scott, N. Narayanan, J. Simmering (Iowa City, USA)
Dopaminergic Medication Changes Following LFP-Guided Deep Brain Stimulation Programming in Parkinson’s Disease: A Single-Centre Audit

M. Pagan, F. Kotsi, M. Boca (Gloucester, United Kingdom)
Dopaminergic Modulation Of Contextual Emotional Appraisal And Shame In Parkinson’s Disease

S. Catalano Chiuve, D. Benis, C. Rime, M. Maradan-Gachet, J. Potheegadoo, F. Bernasconi, O. Blanke, P. Krack, V. Fleury (Geneva, Switzerland)
Dopaminergic reconfiguration of an inverted network hierarchy in Parkinson’s disease

Z. Zhang, T. Feng (Beijing, China)
Dorsal STN and Zona Incerta Stimulation as a Strategy to Reduce Dyskinesia after STN-DBS: A Case Series with Literature Reviews

O. Phokaewvarangkul, K. Katawatee, R. Seeluangsawat, K. Sanyawat, N. Rattanapitak, R. Bhidayasiri (Bangkok, Thailand)
Drivers of Navigated Walking Performance in Aging and Parkinson’s Disease: Insights From Behavioral Clustering, Clinical and Neuroimaging Data

A. Kvist, L. Bezuidenhout, H. Johansson, U. Ekman, D. Moulaee Conradsson, F. Albrecht, E. Franzén (Stockholm, Sweden)
Driving Science to Address Early-Onset Parkinson’s Disease in U.S. Military Service Members

W. Hoffman, M. Salas, R. Izurieta, L. Saadatpour, J. Jacobson (JBSA-Lackland, USA)
Dropped Head Syndrome From Combined MT‑TE and MT‑ND1 Mitochondrial Variants

J. Chen, W. Tse (New York, USA)
DTI-ALPS index and its association with dopamine loss, brain metabolism, and motor and cognitive manifestations in Parkinson’s disease

HS. Yoo, CH. Lyoo, YH. Ryu, M. Park (Seoul, Republic of Korea)
DTI-ALPS Insights into Glymphatic Dynamics and Neurovascular Changes in Parkinson’s Disease

G. Yılmaz çakan, A. Bayram, B. Samancı, G. Kızılateş Evin, L. Karşıgil, G. Kenangil, A. Zırh, Y. Samancı (Istanbul, Turkey)
DTI-Based Comparative Analysis of Microstructural Alterations in Parkinson Disease and Atypical Parkinsonism

H. Lin, W. Dai (Urumqi, China)
Dual device-aided therapy in advanced Parkinson’s Disease: combining bilateral deep brain stimulation and continuous subcutaneous foslevodopa/foscarbidopa Infusion

C. Ribacoba Díaz, A. Fernández Revuelta, A. Aldaz Burgoa, E. López Valdés, R. García-Ramos García (Madrid, Spain)
Dual Globus Pallidus Internus and Pallidothalamic Tract Deep Brain Stimulation for Hemichoreodystonia Secondary to Severe COVID-19 Infection: A Case Report

W. Saengphatrachai, P. Srivanitchapoom, Y. Pitakpatapee, S. Nanta-Aree (Bangkok, Thailand)
Dual Task Effect in Posturography Enhances Diagnosis of Functional Ataxia

A. Mezenchuk, K. Evdokimov, A. Belyakova-Bodina, E. Nuzhnyi, E. Fedotova, A. Broutian, S. Illarioshkin (Moscow, Russian Federation)
Dual-Node Neuromodulation of the Basal Ganglia Motor Circuit: Sequential STN–GPi Stimulation in Advanced Parkinson’s Disease

J. Brainer Lima, P. Brainer Lima, M. Notaro Cavalcanti, A. Brainer Lima, M. Sales, G. Brainer Britto, P. Brainer Lima (Recife, Brazil)
Dual-site rTMS for Essential Tremor

A. Falcone, T. Caetano, M. Soares, C. Tanaka, K. Montes-Silva, E. Reis Barbosa, R. Benhart Carra, R. Gisbert Cury (São Paulo, Brazil)
Dual-Site Transcranial Magnetic Stimulation Ameliorates Freezing of Gait in Parkinson’s Disease by Remodeling Cortical Excitatory-Inhibitory Balance and White Matter Microstructure: A Randomized Controlled Trial

C. Gan, K. Zhang (Nanjing, China)
Dual-Task Cost Assessment in Parkinson’s Disease: A Literature Review of Clinical Applications and Measurement Approaches

C. Balasubramanian, Z. Board, J. Thomas, H. Malik, S. Bagdadi, I. Khan, K. Mangipudi (Jacksonville, USA)
Dual-Task Gait Costs are not Reduced by Immediate Repetition in Parkinson’s Disease

G. Koitla, P. Silva, H. Bernini, V. Silva, L. Aranha, D. Garcia, M. Santos, G. Santos, L. Santos, H. Santos, M. Piemonte (São Paulo, Brazil)
Dual-Task Gait Costs do not Increase Across Stages of Parkinson’s Disease

H. Bernini, G. Koitla, V. Silva, L. Santos, L. Aranha, D. Garcia, M. Santos, G. Santos, P. Silva, M. Piemonte (São Paulo, Brazil)
Dynamic and Multimodal Prediction of Phenoconversion to Cerebellar Multiple Sytem Atrophy among Sporadic Late-Onset Cerebellar Ataxia

T. Wirth, A. Storck, T. Bogdan, I. Pei, IJ. Namer, S. Kremer, C. Tranchant, M. Anheim (Strasbourg, France)
Dynamic Neural States underlying Freezing of Gait in Parkinson’s Disease

Y. Tian, E. Matar, S. Berkovsky, S. Lewis (North Ryde, Australia)
Dynamics of Motor Fluctuations and Medication Challenges in Parkinson’s Disease

O. Udomsirithamrong, R. Bhidayasiri, P. Panyakeaw (Bangkok, Thailand)
Dyskinesia-Hyperpyrexia Syndrome Mimicking a Generalized Seizure in Parkinson’s Disease

B. Kim, D. Jung, I. Song (Seoul, Republic of Korea)
Dysphagia and Oropharyngeal Freezing in Progressive Supranuclear Palsy

P. Wang, Y. Xia, B. Wang, W. Luo, B. Xiong, W. Luo (Hangzhou, China)
Dysregulation of lysosomal lipid microdomains impairs autophagic flux in GBA-associated Parkinson’s disease

M. Chen, F. Liu, Y. Sun, Y. Yang, J. Wang (Shanghai, China)
Dysregulation of the Intestinal Macrophage CXCL8/CXCR2 Axis and Its Role in α-Synuclein Clearance

H. Hu, T. Tang, W. Wang (Shanghai, China)
Dystonia 3×3: A training framework for beginners in botulinum neurotoxin treatment of cervical dystonia

S. Paus, A. Funke, J. Hamacher, J. Heckelmann, CW. Ip, W. Jost, A. Kivi, S. Klebe, JI. Lee, E. Lohmann, F. Mack, A. Schramm, A. Stenner, P. Tacik, U. Walter, D. Weise (Troisdorf-Sieglar, Germany)
Dystonia parkinsonism revealing CV2 positive autoimmune encephalitis

O. Sakli, R. Zouari, Z. Saied, F. Nabli, S. Ben Sassi (Tunis, Tunisia)
Dystonias in a Nigerian Tertiary Hospital: A Case Series Highlighting Diagnostic and Therapeutic Challenges and a Five-Year Retrospective Review

I. Ndionuka, C. Okereke, K. Onwuka, K. Okorie, I. Onwuekwe (Ituku-Ozalla, Nigeria)